Evidence map›Paper›PMID 26376613›Full record

SynthesisOncotarget2015

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma.

Heba Alshaker, Keith Sacco, Albandri Alfraidi, Aun Muhammad, Mathias Winkler, Dmitri Pchejetski

Open access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Antiobesity effects of onion (Food science & nutrition · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Role of Leptin in Inflammation and Vice Versa.International journal of molecular sciences · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Total flavonoids extracted fromBioscience reports · 2019
    Article
  20. The influence of leptin on the process of carcinogenesis.Contemporary oncology (Poznan, Poland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Heba AlshakerDepartment of Surgery and Cancer, Imperial College London, London, UK.
Keith SaccoUniversity of Malta Medical School, Mater Dei Hospital, Tal-Qroqq, MSD, Malta.
Albandri AlfraidiDepartment of Surgery and Cancer, Imperial College London, London, UK.
Aun MuhammadDepartment of Surgery and Cancer, Imperial College London, London, UK.
Mathias WinklerDepartment of Surgery and Cancer, Imperial College London, London, UK.
Dmitri PchejetskiSchool of Medicine, University of East Anglia, Norwich, UK.
Imperial College London · GBUniversity of East Anglia · GBUniversity of Malta · MT

Funding

Prostate Cancer UK PG12-14
6 · The paper itself

Abstract

The prevalence of global obesity is increasing. Obesity is associated with general cancer-related morbidity and mortality and is a known risk factor for development of specific cancers. A recent large systematic review of 24 studies based on meta-analysis of 11,149 patients with prostate cancer showed a significant correlation between obesity and the risk of advanced prostate cancer. Further, a sustained reduction in BMI correlates with a decreased risk of developing aggressive disease. On the other hand, the correlation between consuming different products and prostate cancer occurrence/risk is limited.Here, we review the role of adipose tissue from an endocrine perspective and outline the effect of adipokines on cancer metabolism, with particular focus on leptin. Leptin exerts its physiological and pathological effects through modification of intracellular signalling, most notably activating the Janus kinase (JAK) 2/signal transducer and activator of transcription (STAT) 3 pathway and recently shown sphingolipid pathway. Both high levels of leptin in circulation and leptin receptor mutation are associated with prostate cancer risk in human patients; however, the in vivo mechanistic evidence is less conclusive.Given the complexity of metabolic cancer pathways, it is possible that leptin may have varying effects on prostate cancer at different stages of its development, a point that may be addressed by further epidemiological studies.

Indexed as

Adipose TissueAnimalsCarcinogenesisGenetic Predisposition to DiseaseHumansJanus KinasesLeptinMaleObesityPolymorphism, GeneticProstatic NeoplasmsReceptors, LeptinSignal TransductionSTAT3 Transcription FactorJanus KinasesLeptinReceptors, LeptinSTAT3 Transcription Factorleptinmortalityobesityprogressionprostate cancer

Identifiers

PMID26376613
PMCPMC4742124
OpenAlexW1943984237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.